Stock SYNA BIOP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company SYNA BIOP Nasdaq

Equities

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for SYNA BIOP
2015 Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal RE

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,163,036 36,788,914 ( 98.99 %) 0 98.99 %

Company contact information

Synageva BioPharma Corp.

33 Hayden Avenue

02421, Lexington

+

http://www.synageva.com
address SYNA BIOP

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+25.83% 47.96B
LONZA GROUP AG Stock Lonza Group AG
+45.55% 41.47B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.69% 42.45B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+30.52% 31.6B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+22.30% 28.63B
CELLTRION, INC. Stock Celltrion, Inc.
-6.35% 28.03B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+49.25% 14.56B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+49.18% 14.14B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.45% 12.58B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Company SYNA BIOP